{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:16:41Z","timestamp":1770139001610,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Agir \u00e0 Dom","award":["-"],"award-info":[{"award-number":["-"]}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014089","name":"Boehringer Ingelheim France","doi-asserted-by":"crossref","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100014089","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007560","name":"Chiesi","doi-asserted-by":"crossref","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"crossref"}]},{"name":"GSK","award":["-"],"award-info":[{"award-number":["-"]}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PneumRX","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12931-019-1156-1","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T08:03:22Z","timestamp":1566288202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Are there specific clinical characteristics associated with physician\u2019s treatment choices in COPD?"],"prefix":"10.1186","volume":"20","author":[{"name":"COLIBRI COPD\u00a0Research Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3162-5033","authenticated-orcid":false,"given":"Nicolas","family":"Roche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anestis","family":"Antoniadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Kelkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Pison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-R\u00e9gis","family":"Burgel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Aguilaniu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,20]]},"reference":[{"issue":"3","key":"1156_CR1","doi-asserted-by":"publisher","first-page":"1700214","DOI":"10.1183\/13993003.00214-2017","volume":"49","author":"Claus F. Vogelmeier","year":"2017","unstructured":"Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DMG, L\u00f3pez Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;49(3). \n                    https:\/\/doi.org\/10.1183\/13993003.00214-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"issue":"2","key":"1156_CR2","doi-asserted-by":"publisher","first-page":"1602200","DOI":"10.1183\/13993003.02200-2016","volume":"49","author":"Marc Miravitlles","year":"2017","unstructured":"Miravitlles M, Anzueto A. A new two-step algorithm for the treatment of COPD. Eur Respir J. 2017;49(2). \n                    https:\/\/doi.org\/10.1183\/13993003.02200-2016\n                    \n                  .","journal-title":"European Respiratory Journal"},{"key":"1156_CR3","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.rmed.2013.09.013","volume":"107","author":"PNR Dekhuijzen","year":"2013","unstructured":"Dekhuijzen PNR, Vincken W, Virchow JC, Roche N, Agusti A, Lavorini F, van Aalderen WM, Price D. Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach. Respir Med. 2013;107:1817\u201321.","journal-title":"Respir Med"},{"key":"1156_CR4","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2147\/COPD.S130482","volume":"12","author":"GJ Rodrigo","year":"2017","unstructured":"Rodrigo GJ, Price D, Anzueto A, Singh D, Altman P, Bader G, Patalano F, Fogel R, Kostikas K. LABA\/LAMA combinations versus LAMA monotherapy or LABA\/ICS in COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2017;12:907\u201322.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1156_CR5","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/S0140-6736(17)30188-5","volume":"389","author":"J Vestbo","year":"2017","unstructured":"Vestbo J, Papi A, Corradi M, Blazhko V, Montagna I, Francisco C, Cohuet G, Vezzoli S, Scuri M, Singh D. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial. Lancet. 2017;389:1919\u201329.","journal-title":"Lancet"},{"key":"1156_CR6","first-page":"351","volume":"11","author":"Y Shen","year":"2014","unstructured":"Shen Y, Cai W, Lei S, Zhang Z. Effect of high\/low dose N-acetylcysteine on chronic obstructive pulmonary disease: a systematic review and meta-analysis. COPD. 2014;11:351\u20138.","journal-title":"COPD"},{"issue":"2","key":"1156_CR7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1183\/13993003.01170-2015","volume":"47","author":"Marc Miravitlles","year":"2016","unstructured":"Miravitlles M, Vogelmeier C, Roche N, Halpin D, Cardoso J, Chuchalin AG, Kankaanranta H, Sandstr\u00f6m T, \u015aliwi\u0144ski P, Zatloukal J, Blasi F. A review of national guidelines for management of COPD in Europe. Eur Respir J. 2016. \n                    https:\/\/doi.org\/10.1183\/13993003.01170-2015\n                    \n                  .","journal-title":"European Respiratory Journal"},{"key":"1156_CR8","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(15)60693-6","volume":"385","author":"PG Woodruff","year":"2015","unstructured":"Woodruff PG, Agusti A, Roche N, Singh D, Martinez FJ. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet. 2015;385:1789\u201398.","journal-title":"Lancet"},{"issue":"145","key":"1156_CR9","doi-asserted-by":"publisher","first-page":"170088","DOI":"10.1183\/16000617.0088-2017","volume":"26","author":"Renaud Louis","year":"2017","unstructured":"Louis R, Roche N. Personalised medicine: are we ready? Eur Respir Rev. 2017;26 Available from: \n                    http:\/\/err.ersjournals.com\/content\/26\/145\/170088.abstract\n                    \n                  .","journal-title":"European Respiratory Review"},{"key":"1156_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S2213-2600(17)30217-5","volume":"5","author":"M Bafadhel","year":"2017","unstructured":"Bafadhel M, Pavord ID, Russell REK. Eosinophils in COPD: just another biomarker? Lancet Respir Med. 2017;5:747\u201359.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"1156_CR11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/09031936.01.00213701","volume":"18","author":"N Roche","year":"2001","unstructured":"Roche N, Lepage T, Bourcereau J, Terrioux P. Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J. 2001;18(6):903\u20138.","journal-title":"Eur Respir J"},{"key":"1156_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1183\/09031936.02.01302001","volume":"20","author":"M Miravitlles","year":"2002","unstructured":"Miravitlles M. Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J. 2002;20:243\u20134.","journal-title":"Eur Respir J"},{"key":"1156_CR13","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2147\/COPD.S103614","volume":"11","author":"JL L\u00f3pez-Campos","year":"2016","unstructured":"L\u00f3pez-Campos JL, Abad Arranz M, Calero Acu\u00f1a C, Romero Valero F, Ayerbe Garc\u00eda R, Hidalgo Molina A, Aguilar Perez-Grovas RI, Garc\u00eda Gil F, Casas Maldonado F, Caballero Ballesteros L, S\u00e1nchez Palop M, P\u00e9rez-Tejero D, Segado A, Calvo Bonachera J, Hern\u00e1ndez Sierra B, Dom\u00e9nech A, Arroyo Varela M, Gonz\u00e1lez Vargas F, Cruz Rueda JJ. Determinants for changing the treatment of COPD: a regression analysis from a clinical audit. Int J Chron Obstruct Pulmon Dis. 2016;11:1171\u20138.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1156_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.rmed.2014.03.002","volume":"108","author":"J Vestbo","year":"2014","unstructured":"Vestbo J, Vogelmeier C, Small M, Higgins V. Understanding the GOLD 2011 strategy as applied to a real-world COPD population. Respir Med. 2014;108:729\u201336.","journal-title":"Respir Med"},{"key":"1156_CR15","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.rmed.2012.03.008","volume":"106","author":"A Corrado","year":"2012","unstructured":"Corrado A, Rossi A. How far is real life from COPD therapy guidelines? An Italian observational study. Respir Med. 2012;106:989\u201397.","journal-title":"Respir Med"},{"issue":"Suppl A","key":"1156_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1155\/2006\/810978","volume":"13","author":"L Boulet","year":"2006","unstructured":"Boulet L, Becker A, Bowie D, McIvor A, Hernandez P, Rouleau M, Bourbeau J, Graham I, Legare F, Ward T, Cowie R, Drouin D, Harris SB, Tamblyn R, Ernst P, Tan WC, Partridge M, Godard P, Herrerias C, Wilson J, Stirling L, Rozitis EB, Garvey N, Lougheed D, Labrecque M, Rea R, Holroyde M, Fagnan D, Dorval E, Pogany L, et al. Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J. 2006;13(Suppl A):5\u201347.","journal-title":"Can Respir J"},{"key":"1156_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.rmr.2015.02.090","volume":"33","author":"E Kelkel","year":"2016","unstructured":"Kelkel E, Herengt F, Ben Saidane H, Veale D, Jeanjean C, Pison C, Pernot J, P\u00e9pin J-L, Guillaud-Segard B, Gonzalez-Bermejo J, Aguilaniu B. COLIBRI: improving clinical practice and producing relevant scientific data. Rev Mal Respir. 2016;33:5\u201316.","journal-title":"Rev Mal Respir"},{"key":"1156_CR18","first-page":"387","volume":"6","author":"B Aguilaniu","year":"2011","unstructured":"Aguilaniu B, Gonzalez-Bermejo J, Regnault A, Barbosa CD, Arnould B, Mueser M, Granet G, Bonnefoy M, Similowski T. Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice. Int J Chron Obstruct Pulmon Dis. 2011;6:387\u201398.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1156_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/10618600.2012.701379","volume":"22","author":"G Tutz","year":"2013","unstructured":"Tutz G, Schauberger G. Visualization of categorical response models: from data glyphs to parameter glyphs. J Comput Graph Stat. 2013;22:156\u201377.","journal-title":"J Comput Graph Stat"},{"key":"1156_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/01621459.1994.10476460","volume":"89","author":"M Friendly","year":"1994","unstructured":"Friendly M. Mosaic displays for multi-way contingency tables. J Am Stat Assoc. 1994;89:190\u2013200.","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"1156_CR21","doi-asserted-by":"publisher","first-page":"1701250","DOI":"10.1183\/13993003.01250-2017","volume":"50","author":"Maeva Zysman","year":"2017","unstructured":"Zysman M, Chabot F, Housset B, Morelot Panzini C, Devillier P, Roche N. Soci\u00e9t\u00e9 de Pneumologie de Langue Fran\u00e7aise. Pharmacological treatment optimisation for stable COPD: an endless story? Proposals from the Soci\u00e9t\u00e9 de Pneumologie de Langue Fran\u00e7aise. Eur Respir J. 2017;50(4). \n                    https:\/\/doi.org\/10.1183\/13993003.01250-2017\n                    \n                  .","journal-title":"European Respiratory Journal"},{"key":"1156_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/COPD.S122013","volume":"12","author":"JC Simeone","year":"2017","unstructured":"Simeone JC, Luthra R, Kaila S, Pan X, Bhagnani TD, Liu J, Wilcox TK. Initiation of triple therapy maintenance treatment among patients with COPD in the US. Int J Chron Obstruct Pulmon Dis. 2017;12:73\u201383.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1156_CR23","first-page":"1053","volume":"10","author":"M Miyazaki","year":"2015","unstructured":"Miyazaki M, Nakamura H, Takahashi S, Chubachi S, Sasaki M, Haraguchi M, Terai H, Ishii M, Fukunaga K, Tasaka S, Soejima K, Asano K, Betsuyaku T, Keio COPD Comorbidity Research (K-CCR) group. The reasons for triple therapy in stable COPD patients in Japanese clinical practice. Int J Chron Obstruct Pulmon Dis. 2015;10:1053\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1156_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.rmed.2014.01.002","volume":"108","author":"H Magnussen","year":"2014","unstructured":"Magnussen H, Watz H, Kirsten A, Decramer M, Dahl R, Calverley PMA, Towse L, Finnigan H, Tetzlaff K, Disse B. Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale. Respir Med. 2014;108:593\u20139.","journal-title":"Respir Med"},{"key":"1156_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2147\/COPD.S125616","volume":"12","author":"C Vogelmeier","year":"2017","unstructured":"Vogelmeier C, Worth H, Buhl R, Cri\u00e9e C-P, Lossi NS, Mail\u00e4nder C, Kardos P. \u201cReal-life\u201d inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD. Int J Chron Obstruct Pulmon Dis. 2017;12:487\u201394.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1156_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2466-12-39","volume":"12","author":"N Roche","year":"2012","unstructured":"Roche N, Chouaid C, Delclaux B, Martinat Y, Marcos J-M, P\u00e9gliasco H, Scherrer B. Multidimensional analyses to assess the relations between treatment choices by physicians and patients\u2019 characteristics: the example of COPD. BMC Pulm Med. 2012;12:39.","journal-title":"BMC Pulm Med"},{"key":"1156_CR27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1183\/09031936.00162313","volume":"43","author":"P-R Burgel","year":"2014","unstructured":"Burgel P-R, Desl\u00e9e G, Jebrak G, Brinchault G, Caillaud D, Chanez P, Court-Fortune I, Escamilla R, Nesme-Meyer P, Paillasseur J-L, Perez T, Roche N, Initiatives BPCO scientific committee. Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011? Eur Respir J. 2014;43:1201\u20133.","journal-title":"Eur Respir J"},{"key":"1156_CR28","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst JR, Vestbo J, Anzueto A, Locantore N, M\u00fcllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EFM, Wedzicha JA. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128\u201338.","journal-title":"N Engl J Med"},{"key":"1156_CR29","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3109\/15412555.2014.948999","volume":"12","author":"SJ Park","year":"2015","unstructured":"Park SJ, Make B, Hersh CP, Bowler RP. Significance of medication history at the time of entry into the COPDGene study: relationship with exacerbation and CT metrics. COPD. 2015;12:366\u201373.","journal-title":"COPD"},{"key":"1156_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41533-017-0040-z","volume":"27","author":"JD Chalmers","year":"2017","unstructured":"Chalmers JD, Tebboth A, Gayle A, Ternouth A, Ramscar N. Determinants of initial inhaled corticosteroid use in patients with GOLD a\/B COPD: a retrospective study of UK general practice. NPJ Prim Care Respir Med. 2017;27:43.","journal-title":"NPJ Prim Care Respir Med"},{"key":"1156_CR31","doi-asserted-by":"publisher","first-page":"1409060","DOI":"10.1080\/20018525.2017.1409060","volume":"4","author":"J Sundh","year":"2017","unstructured":"Sundh J, \u00c5berg J, Hasselgren M, Montgomery S, St\u00e4llberg B, Lisspers K, Janson C. Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014. Eur Clin Respir J. 2017;4:1409060.","journal-title":"Eur Clin Respir J"},{"key":"1156_CR32","doi-asserted-by":"crossref","unstructured":"Ding B, Small M, Holmgren U. A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications. Int J Chron Obstruct Pulmon Dis. 2017; Cited 2017 Dec 31. Available from: \n                    https:\/\/www.dovepress.com\/a-cross-sectional-survey-of-current-treatment-and-symptom-burden-of-pa-peer-reviewed-article-COPD\n                    \n                  .","DOI":"10.2147\/COPD.S133793"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1156-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-019-1156-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1156-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:53Z","timestamp":1597795253000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-019-1156-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1156"],"URL":"https:\/\/doi.org\/10.1186\/s12931-019-1156-1","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,20]]},"assertion":[{"value":"6 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The database has been authorised by the French national commission on personal data privacy (Commission Nationale de l\u2019Informatique et des Libert\u00e9s, CNIL, authorisation number # 2013\u2013526) after a positive advice from the committee on health data management for research purposes (Comit\u00e9 Consultatif sur le Traitement de l\u2019Information en mati\u00e8re de Recherche dans le domaine de la Sant\u00e9, CCTIRS). The requirement for written consent was waived due to the observational character of the study, in accordance with French law. Patients provided oral consent following information by their physician.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NR reports grants and personal fees from Boehringer Ingelheim, Novartis, Pfizer and personal fees from Teva, GSK, AstraZeneca, Chiesi, Mundipharma, Cipla, Sanofi, Sandoz, 3\u2009M, Zambon.PRB reports personal fees from Astra-Zeneca, Boehringer Ingelheim France, Chiesi, GSK, Novartis, Pfizer, Vertex, Zambon, Teva.CP reports grants and personal fees from GSK France, personal fees from Novartis France, BIF and AZ France.AA, BA, EK, SL have nothing to disclose.DH is employed by Association pour la Compl\u00e9mentarit\u00e9 des Connaissances et des Pratiques de la Pneumologie, Grenoble using funds from Agir \u00e0 Dom, AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Novartis, PneumRx.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}